Toggle Navigation
open search bar
share with emailshare with Facebookshare with Twittershare with Pinterestshare with LinkedIn

Hair Loss and Cancer – Chemotherapy Does Not Need To Lead To Hair Loss Anymore

7 Min Read

Hair Loss and cancer – as if the dreaded disease isn’t bad enough it usually comes with the added burden of hair loss. So when the news hit the world of a new device that helps cancer patients keep their hair during chemotherapy, cancer patients everywhere felt there might be a small amount of relief to everything they already have to deal with.

DigniCap is the name of the device that is supposed to revolutionize hair loss during chemotherapy. It is a scalp cooling system that offers patients the possibility of keeping all or most of their hair during chemotherapy. According to DigniCap, the cooling system was approved by the FDA for use in the U.S. in December 2015.

Modern medicine has come a long way when it comes to handling the side effects of chemotherapy, making many aspects of the treatment manageable for the patients. But hair loss has been one of the side effects that for a long time was unavoidable. Many patients going through chemotherapy has said that they do not like the fact that hair loss makes it so obvious to others that they are are sick.

Dr. Saranya Chumsri, an oncologist specializing in breast cancer at the Mayo Clinic in Jacksonville, a clinic that now offers their patients DigniCap, said in an interview for the local paper that many patients do not want to be reminded they have cancer.

“Even though they, most of the time, feel really well, the fact that they don’t have hair reminds them every single day that they have cancer and are on chemotherapy. With the DigniCap system, just the fact they can keep their hair makes a whole world of difference,” said Dr Chumsri.

How Dignicap Works When Dealing with Cancer and Hair Loss

The DigniCap scalp cooling system is a tight-fitting silicone cooling cap. The cap is placed directly on the head of the person. And an outer cap is placed on the first silicone cap, and insulates and secures it.

The cap is connected to a cooler, where liquid coolant circulates throughout the silicone cap, delivering cooling to all areas of the scalp. Before the patients put on the cap, they wet their hair, and sometimes, when the treatment is done, they can actually find ice crystals in their hair. The temperature of the scalp is lowered and the scalp is kept cold, and because of that, less chemotherapy makes it to the scalp.

These are the factors that reduce the risk of hair loss. What determines how long the patients will be attached to the DigniCap, is the treatment that they are getting. But it usually last from four to seven hours.

More and more clinics are integrating Dignicap as part of the post-cancer treatment.

Still Unattainable for Most People

Even though DigniCap is revolutionizing the battle of cancer and hair loss, it is still a tool that is mainly for those who can afford it. Using DigniCap is not cheap. In fact, it costs about $400 for each treatment.

Other problems that have been reported are that some of the patients get a headache from the cap, and that the strap on the cap can give some patients irritations on the chin. Nonetheless, more and more clinics are integrating DigniCap as part of their post-cancer treatment, making it a great development when it comes to cancer and hair loss.

William Cronin, the Chief Executive Officer of Dignitana Inc, the company that produces DigniCap, says in an article that he is honored to make a real difference for cancer patients who fear losing their hair to chemotherapy.

“As more and more centers like the Mayo Clinic integrate new innovations like the DigniCap system into their cancer care regimens, we move closer and closer to the day when that fear is a thing of the past,” he comments.

share with emailshare with Facebookshare with Twittershare with Pinterestshare with LinkedIn

Sign up for the Nutrafol Newsletter

© 2024 Nutraceutical Wellness Inc. All Rights Reserved.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.